BTI
RGEN icon

Blue Trust Inc’s Repligen RGEN Stock Holding History

Blue Trust Inc’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.32K Buy
61
+41
+205% +$5.04K ﹤0.01% 1909
2026
Q1 		$2.36K Hold
20
– – ﹤0.01% 2107
2025
Q4 		$3.28K Hold
20
– – ﹤0.01% 2065
2025
Q3 		$2.67K Hold
20
– – ﹤0.01% 2106
2025
Q2 		$2.49K Hold
20
– – ﹤0.01% 2106
2025
Q1 		$2.54K Buy
+20
New +$3.08K ﹤0.01% 2198
2024
Q4 		– Sell
-239
Closed -$30.1K – 2872
2024
Q3 		$30.1K Buy
239
+127
+113% +$18.2K ﹤0.01% 1782
2024
Q2 		$20.6K Buy
112
+41
+58% +$6.43K ﹤0.01% 1646
2024
Q1 		$13.1K Buy
71
+1
+1% +$190 ﹤0.01% 1375
2023
Q4 		$11K Sell
70
-41
-37% -$6.38K ﹤0.01% 1557
2023
Q3 		$16K Buy
111
+37
+50% +$6.05K ﹤0.01% 1252
2023
Q2 		$12K Sell
74
-67
-48% -$10.7K ﹤0.01% 1248
2023
Q1 		$24K Buy
141
+46
+48% +$8.21K ﹤0.01% 1309
2022
Q4 		$18K Buy
95
+38
+67% +$6.89K ﹤0.01% 1329
2022
Q3 		$9K Buy
57
+36
+171% +$7.59K ﹤0.01% 1386
2022
Q2 		$4K Buy
+21
New +$3.32K ﹤0.01% 1519

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Blue Trust Inc's RGEN Position: Q2 2026 in Review

Blue Trust Inc increased its Repligen (RGEN) stake by 205% in Q2 2026, buying an estimated $5.04K and bringing the position to 61 shares worth $8.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

Blue Trust Inc first reported a position in RGEN in Q2 2022 and has held it in 16 quarters since. The position peaked at $30.1K in Q3 2024. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Blue Trust Inc held 61 shares of Repligen worth $8.32K as of Q2 2026.
  • Blue Trust Inc bought 41 Repligen shares in Q2 2026, an estimated $5.04K.
  • Repligen made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1909 holding.
  • Blue Trust Inc first reported a position in Repligen in Q2 2022 and has held it in 16 quarters since.
  • Blue Trust Inc's Repligen position peaked at $30.1K in Q3 2024.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.